Novozymes A/S (CPH:NSIS.B)
Denmark · Delayed Price · Currency is DKK 426.50
+0.70 (0.16%)
Jul 3, 2026, 4:59 PM CET
Novozymes Market Cap
Novozymes has a market cap or net worth of 198.71 billion as of July 2, 2026. Its market cap has decreased by -11.47% in one year.
Market Cap
198.71B
Enterprise Value
220.28B
Revenue
31.39B
Ranking
n/a
PE Ratio
44.63
Stock Price
426.50
Market Cap Chart
Since February 26, 2001, Novozymes's market cap has increased from 14.15B to 198.71B, an increase of 1,304.50%. That is a compound annual growth rate of 10.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 198.71B | 4.65% |
| Dec 30, 2025 | 189.89B | 0.24% |
| Dec 30, 2024 | 189.43B | 84.24% |
| Dec 29, 2023 | 102.82B | 5.66% |
| Dec 30, 2022 | 97.30B | -34.61% |
| Dec 30, 2021 | 148.80B | 51.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DSV A/S | 396.33B |
| Danske Bank | 293.32B |
| A.P. Møller - Mærsk | 236.76B |
| Ørsted | 209.45B |
| Vestas Wind Systems | 184.38B |
| Carlsberg | 127.69B |
| Genmab | 114.71B |
| Coloplast | 88.92B |